ストックスクリーナーアプリを入手
7.02
5.09%
0.34
前日終値:
$6.68
開ける：
$6.62
24時間の取引高:
106.87K
Relative Volume:
0.60
時価総額：
$254.78M
収益：
$8.98M
当期純損益:
$-31.39M
株価収益率:
-5.2388
EPS:
-1.34
ネットキャッシュフロー:
$-24.83M
1週間 パフォーマンス:
+9.01%
1か月 パフォーマンス:
-14.60%
6か月 パフォーマンス:
+47.79%
1年 パフォーマンス:
+3.39%
1日の値動き範囲:
$6.5385
$7.11
1週間の範囲:
$6.00
$7.11
52週間の値動き範囲:
$3.76
$8.95
Profound Medical Corp Stock (PROF) Company Profile
名前
Profound Medical Corp
セクター
電話
647-476-1350
住所
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
7.02 | 242.44M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-23 | 開始されました | Lake Street | Buy |
| 2024-07-16 | アップグレード | Stifel | Hold → Buy |
| 2023-11-28 | 開始されました | Stifel | Hold |
| 2023-08-04 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | ダウングレード | Jefferies | Buy → Hold |
| 2020-09-15 | 開始されました | Jefferies | Buy |
すべてを表示
Profound Medical Corp (PROF) 最新ニュース
Profound Medical launches up to $40 million equity financing to support growth - MSN
(PRN) Strategic Market Analysis (PRN:CA) - Stock Traders Daily
Buy Signal: How does Profound Medical Corp perform in inflationary periods2025 Performance Recap & Community Driven Trade Alerts - baoquankhu1.vn
What margin trends mean for Profound Medical Corp. stockChart Signals & Accurate Trade Setup Notifications - mfd.ru
(PRN) Strategic Investment Guide (PRN:CA) - Stock Traders Daily
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th Conference Call to Follow - marketscreener.com
Risks Still Elevated At These Prices As Profound Medical Corp. (TSE:PRN) Shares Dive 27% - simplywall.st
Profound Medical Schedules Q4 and 2025 Results Call - TipRanks
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow - marketscreener.com
Profound Medical Honored with INOVAIT's 2025-2026 Mount Logan Award Recognizing the TULSA Procedure for Prostate Disease - Bitget
Profound Medical Earns INOVAIT Award, Accelerates TULSA Expansion - TipRanks
Profound Medical Honored with INOVAIT’s 2025-2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease - The Manila Times
Profound Medical Corp Receives 2025-2026 Mount Logan Award - TradingView
New prostate treatment earns Canadian tech its Mount Logan prize - Stock Titan
(PRN) Strategic Equity Report (PRN:CA) - Stock Traders Daily
Aug Sectors: Is Profound Medical Corp in a bullish channelWatch List & Consistent Income Trade Ideas - baoquankhu1.vn
(PRN) On The My Stocks Page (PRN:CA) - Stock Traders Daily
Profound Medical Corp.'s (TSE:PRN) market cap dropped CA$42m last week; individual investors who hold 56% were hit as were institutions - simplywall.st
Profound Medical (PROF) Celebrates Milestone in Poland with 500t - GuruFocus
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women's Health - Investing News Network
Profound Medical Marks 500th Sonalleve Procedure Milestone - TipRanks
Profound Medical Corp Celebrates 500th Sonalleve® Procedure at PRO FAMILIA - TradingView
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health - The Manila Times
500 incision-free uterine treatments completed at Polish hospital - Stock Titan
Death Cross: What hedge funds are buying Profound Medical CorpBull Run & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Market Outlook: Is LBRDK in a consolidation phaseWeekly Stock Summary & Long-Term Investment Growth Plans - baoquankhu1.vn
Analyzing Profound Medical (NASDAQ:PROF) & Reviva Pharmaceuticals (NASDAQ:RVPH) - Defense World
Opinion: This Is the Only TSX Growth Stock to Own for the Next 3 Years - Yahoo! Finance Canada
Profound Medical (NASDAQ:PROF) Shares Down 1.3%Should You Sell? - MarketBeat
Profound Medical to Engage Investors at February Life Sciences Conferences - TipRanks
Profound Medical Corp Announces Upcoming Investor Events - TradingView
Profound Medical Announces Upcoming Investor Events - The Manila Times
How To Trade (PRN) (PRN:CA) - Stock Traders Daily
Johns Hopkins Medicine Initiates Use of Profound Medical’s TULSA-PRO System - Medical Product Outsourcing
(PROF) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Profound Medical raises US$6.45 million in Canadian private placement - MSN
Profound Medical’s TULSA-PRO marks first commercial case at Johns Hopkins - MSN
(PRN) Daily Stock Insights (PRN:CA) - Stock Traders Daily
Investors in Profound Medical (TSE:PRN) have unfortunately lost 67% over the last five years - Yahoo Finance
Profound Medical upsizes private placement to raise US$6.45 million - MSN
Profound Medical (PROF) Soars 9.5%: Is Further Upside Left in the Stock? - Yahoo Finance
Profound Medical (PROF) Introduces TULSA-PRO at Mount Sinai Hosp - GuruFocus
Long Term Trading Analysis for (PRN) (PRN:CA) - Stock Traders Daily
Profound Medical Expands TULSA-PRO Use at Mount Sinai - TipRanks
AI-guided, incision-free prostate treatment debuts at Mount Sinai - Stock Titan
Profound Medical (TSE:PRN) Hits New 1-Year HighTime to Buy? - MarketBeat
Profound Medical Exceeds 2025 TULSA-PRO Installation Target and Grows Sales Pipeline - The Globe and Mail
Objective long/short (PRN) Report (PRN:CA) - Stock Traders Daily
Profound Medical Corp Surpasses 2025 TULSA-PRO® Installation Goal - TradingView — Track All Markets
Profound Surpasses 2025 TULSA-PRO Installed Base Goal - 富途资讯
Profound Medical (PROF) Surpasses Installation Goal with TULSA-P - GuruFocus
Profound Medical Corp (PROF) 財務データ
収益
当期純利益
現金流量
EPS
1.13%
大文字化:
|
ボリューム (24 時間):